Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin E with Fruquintinib and Tislelizumab in MSS mCRC
NCT05771181Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vitamin e in colorectal cancer (CRC), sponsored by Fudan University. Primary endpoint: Objective Response Rate at 2 years. Started Mar 2023; status: recruiting.
02
Drugs
vitamin e
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05771181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05771181.